Drug intelligence / Profile preview

diperoxochloric acid

Development stage
Unknown
Lead developer
Centaur Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Diperoxochloric acid (DPOCL) is a first-in-class small molecule New Chemical Entity (NCE) developed by Centaur Pharmaceuticals in collaboration with CytoTools AG for the treatment of diabetic foot ulcers. Formulated as a topical solution and marketed under the brand name WOXheal, it possesses a dual mechanism of action: it exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria and stimulates fibroblast growth to promote wound healing and closure. DPOCL received regulatory approval from the CDSCO in India in 2019 after successful Phase II and Phase III clinical trials, which demonstrated a 76% complete wound closure rate compared to 57.5% in the control group. It was launched in India in 2020 as a first-in-world treatment for this indication.

Brand names
WOXheal

Beyond the preview

Go deeper on diperoxochloric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diperoxochloric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call